1. PB2313: DARATUMUMAB AS A TREATMENT FOR ADULT IMMUNE THROMBOCYTOPENIA: A PHASE II STUDY WITH SAFETY RUN-IN (THE DART STUDY). (23rd June 2022) Authors: Tsykunova, G.; Holme, P. A.; Thi Thyuet Tran, H.; Tvedt, T. H. A.; Munthe, L.; Michel, M.; Frederiksen, H.; Bussel, J.; Kuter, D.; Ghanima, W. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 2182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Β‐1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. (22nd January 2015) Authors: Basciano, P. A.; Matakas, J.; Pecci, A.; Civaschi, E.; Cagioni, C.; Bompiani, N.; Burger, P.; Christos, P.; Snyder, J. P.; Bussel, J.; Balduini, C. L.; Giannakakou, P.; Noris, P. Journal: Journal of thrombosis and haemostasis Issue: Volume 13:Number 4(2015:Apr.) Page Start: 651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗